Related Experiment Videos
Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care
M Boles1, F L Lynch, L L DeBar
1Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon 97227, USA.
Insights
Children with ADHD and co-occurring psychiatric conditions often receive varied psychotropic medications, unlike those with uncomplicated ADHD who primarily use stimulants. This highlights differing treatment patterns for complex pediatric mental health needs.
Area of Science:
- Pediatric Psychiatry
- Pharmacotherapy Research
- Mental Health Services Research
Background:
- Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
- Pharmacological interventions are a cornerstone of ADHD management.
- Understanding treatment patterns is crucial for optimizing care, especially when psychiatric comorbidities are present.
Purpose of the Study:
- To analyze pharmacotherapy patterns for pediatric ADHD within a managed care setting.
- To compare drug treatments between children with uncomplicated ADHD and those with comorbid psychiatric conditions.
- To investigate the link between specialty mental health service utilization and psychotropic medication use in ADHD.
Main Methods:
- Retrospective analysis of patient data from January 1997 to July 1998.
- Comparison of medication use (psychostimulants, antidepressants, alpha-adrenergic agonists) based on ADHD complexity and comorbidity.
- Statistical analysis using odds ratios (OR) and confidence intervals (CI) to assess treatment differences.
Main Results:
- Children with ADHD and psychiatric comorbidity were less likely to use psychostimulants (OR=0.71) but more likely to use antidepressants (OR=2.74), alpha-adrenergic agonists (OR=2.63), and other psychotropic medications.
- Comorbid ADHD cases were also more prone to polypharmacy (multiple psychotropic drugs).
- Uncomplicated ADHD cases predominantly received stimulant-only therapy.
Conclusions:
- Pediatric ADHD treatment varies significantly based on the presence of psychiatric comorbidities.
- Children with more complex mental health needs receive broader and potentially more intensive pharmacotherapy.
- Findings underscore the need for tailored treatment strategies for pediatric ADHD, considering comorbid conditions and service utilization.
Abstract:
The purpose of this study was to identify the patterns of pharmacotherapy in the treatment of children diagnosed with attention deficit hyperactivity disorder (ADHD) in a large, non-profit, group-model managed care organization from January 1997 through July 1998. We sought to determine whether children with uncomplicated ADHD use different drug therapies when compared to children with ADHD and psychiatric comorbidity. We also examined the relationships between the use of specialty mental health services and the use of various psychotropic medications for treatment of ADHD. We found that children with ADHD and psychiatric comorbidity were less likely to use psychostimulants (odds ratio [OR] = 0.71, 95% confidence interval [CI] = 0.55-0.93, p = 0.01) but more likely to use antidepressants (OR = 2.74, 95% CI = 1.95-3.86, p < 0.01), alpha adrenergic agonists (OR = 2.63, 95% CI = 1.93-3.57, p < 0.01), and other psychotropic medications (OR = 2.40, 95% CI = 1.27-4.50, p < 0.01) than children with uncomplicated ADHD (who were more likely to use stimulants only). Additionally, children with psychiatric comorbidity were more likely to use multiple psychotropic drugs (p < 0.01). The results of this study indicate that children with potentially more complex mental health needs are being treated with more varied drug therapy and/or specialty mental health care services.